Pinatuzumab Biosimilar - Anti-CD22 Antibody - BSA and Azide free
Description
Recombinant humanized monoclonal antibody to CD22.
Applications
ELISA
Dilutions
ELISA: 1:5,000-10,000
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Isotype
IgG1
Conjugate
Unconjugated
Purification
Affinity chromatography.
Concentration
Reconstitution dependent.
Product Form
Lyophilized
Reconstitution
Reconstitute with distilled sterile water.
Formulation
Lyophilized from sterile Phosphate Buffered Saline, pH 7.4. Normally 5%–8% Trehalose is added as a protectant before lyophilization.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
General Notes
Prior to reconstitution, centrifuge the vial at 5,000g for 3-5 minutes at room temperature. Reconstitute with appropriate volume of distilled sterile water to bring product to 1mg/ml concentration. After addition of distilled sterile water, mix by gentle tapping. Note: It is not recommended to vortex or vigorously pipette the sample.
ELISA plate pre-coated by 2 µg/ml (100 µl/well) Recombinant Human CD22 Protein (Fc Chimera 6xHis Tag) (A318403) can bind Anti-CD22 Humanized Antibody [Pinatuzumab Biosimilar] - Azide free (A318927) in a linear range of 3.2-400 µg/ml. In order to specifically detect Anti-CD22 Humanized Antibody [Pinatuzumab Biosimilar] - Azide free (A318927), Mouse Anti-Human IgG Fab Antibody was used as detection antibody.
HEK293 cell line transfected with irrelevant protein (B) and human CD22 (A) were surface stained with Anti-CD22 Humanized Antibody [Pinatuzumab Biosimilar] - Azide free (A318927) at 1 µg/ml followed by Anti-Human IgG Antibody (Alexa 488).
Publishing research using Pinatuzumab Biosimilar - Anti-CD22 Antibody - BSA and Azide free (A318927)? Please let us know so that we can list the citation on this page.
Alternative products to Pinatuzumab Biosimilar - Anti-CD22 Antibody - BSA and Azide free (A318927)